Hepatitis C virus and integrated care for substance use disorders

This publication has 27 references indexed in Scilit:

• Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine
  JAMA, 2024
• Temporal trends in HCV treatment uptake and success among people who inject drugs in Baltimore, MD since the introduction of direct acting antivirals
  Drug and Alcohol Dependence, 2023
• Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy
  JAMA Network Open, 2023
• Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
  Drug and Alcohol Dependence Reports, 2022
• HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US
  JAMA, 2022
• A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection
  Hepatology, 2020
• Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review
  International Journal of Drug Policy, 2019
• Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
  Current HIV/AIDS Reports, 2018
• The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study
  Journal of Hepatology, 2018
• Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users
  JAMA Internal Medicine, 2014